Related Experiment Videos
HIV-related nontuberculous mycobacterial infection: incidence, survival analysis and associated risk factors
K N Arastéh1, C Cordes, M Ewers
1Auguste-Viktoria Krankenhaus, Rubensstr. 125, D-12157 Berlin, Germany. arasteh@avk.b.shuttle.de
Abstract:
To evaluate the incidence and survival time for AIDS-patients affected by different stages of nontuberculous mycobacterial (NTM) infection we performed a retrospective study. Data of 1540 hospitalised AIDS-patients was analyzed with respect to survival time and incidence rates. The overall incidence rate of NTM following AIDS was 16.6/100 person-years (PY), with an increase from 12.1/100PY (1987-1990) to 18.9/100PY (1991-1994). Antiretroviral therapy (ART) and toxoplasmosis prophylaxis reduced the risk of NTM disease whereas CD4 cells <40/ microl at time of the first AIDS defining illness led to a 2.5 fold higher risk. Pneumocystis carinii pneumonia (PCP), wasting syndrome and PCP prophylaxis increased the risk of progression from colonization to dissemination. Cryptococcus neoformans infection, wasting syndrome, PCP prophylaxis and CD4 cells <40/ microl were linked to immediate NTM dissemination. Though the incidence of NTM dissemination increased by the factor 1.56 in 1991-1994, survival did not differ between patients with and without NTM infection.
Insights
Nontuberculous mycobacterial (NTM) infections are common in AIDS patients, with incidence increasing over time. However, NTM infection did not impact survival rates in these patients.
Area of Science:
- Infectious Diseases
- Immunology
- Public Health
Background:
- Nontuberculous mycobacterial (NTM) infections pose a significant health challenge for individuals with Acquired Immunodeficiency Syndrome (AIDS).
- Understanding the incidence and prognostic factors of NTM infections in AIDS patients is crucial for clinical management and public health strategies.
Purpose of the Study:
- To determine the incidence rates of NTM infections in hospitalized AIDS patients.
- To analyze survival times in AIDS patients with and without NTM infections.
- To identify risk factors associated with NTM disease and dissemination in the context of AIDS.
Main Methods:
- Retrospective study analyzing data from 1540 hospitalized AIDS patients.
- Evaluation of incidence rates of NTM infections per 100 person-years (PY).
- Statistical analysis to identify factors influencing NTM disease and dissemination, and their impact on survival.
Main Results:
- Overall NTM incidence was 16.6/100 PY, increasing from 12.1/100 PY (1987-1990) to 18.9/100 PY (1991-1994).
- Antiretroviral therapy (ART) and toxoplasmosis prophylaxis decreased NTM risk; CD4 cells <40/microliter increased risk 2.5-fold.
- Pneumocystis carinii pneumonia (PCP), wasting syndrome, and PCP prophylaxis increased progression from colonization to dissemination; Cryptococcus neoformans infection was linked to immediate NTM dissemination.
Conclusions:
- Despite an increased incidence of NTM dissemination, survival rates did not differ between AIDS patients with and without NTM infection.
- Early AIDS-defining illnesses with low CD4 counts and specific opportunistic infections are significant risk factors for NTM disease and dissemination.
- ART and prophylaxis play a role in mitigating NTM risk, highlighting the importance of comprehensive care for AIDS patients.